Formulation and Optimization of Misoprostol-Encapsulated Floating Microbeads for Gastric Ulcer Healing
Oriental Journal Of Chemistry · 01.05.2026 · 2 (42) · 750
DOI: 10.13005/ojc/420236 ↗Kurz gefasst
Fachartikel in der Zeitschrift Oriental Journal Of Chemistry, online erschienen am 30.03.2026. Verfasst von Devidas G. Bachhav und 8 weiteren Autor:innen. Die Arbeit nennt 52 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Misoprostol, a synthetic prostaglandin E₁ analogue, is effective for gastric ulcer healing but suffers from a short half‑life (20–30 min), frequent dosing (3–4 times daily), and dose‑dependent gastrointestinal side effects due to systemic absorption. Gastroretentive floating microbeads offer a strategy to prolong gastric residence and deliver misoprostol locally. Floating microbeads were prepared by extruding a sodium alginate‑misoprostol‑NaHCO₃ dispersion into CaCl₂ solution. A Box‑Behnken design (BBD) was employed to optimize three independent factors: alginate concentration (1.5–2.5% w/v), NaHCO₃ concentration (0.5–1.5% w/v), and CaCl₂ concentration (6–9% w/v). Responses included encapsulation efficiency (%EE), floating lag time (FLT), and cumulative drug release at 12 h. The optimized formulation was characterized for particle size, morphology (SEM), swelling, mucoadhesion, in vitro release kinetics, and stability. In vivo pharmacodynamic study was conducted in an indomethacin‑induced gastric ulcer rat model (n=6/group) comparing optimized microbeads (once daily, 100 µg/kg) with plain misoprostol suspension (twice daily) and marketed Cytotec®. The optimized formulation (2.2% alginate, 1.2% NaHCO₃, 7.2% CaCl₂, alginate:chitosan 2:1) achieved %EE of 89.4 ± 1.6%, FLT of 42 ± 4 s, and 12‑h release of 88.6 ± 2.4%. SEM revealed spherical, porous beads. Release followed Korsmeyer‑Peppas kinetics (n=0.62, anomalous transport). The microbeads exhibited good swelling (183% at 2 h) and mucoadhesion (detachment time 8.2 h). In vivo, optimized beads reduced ulcer index by 83% (vs. 55% for plain drug, p
Zitieren
APA
Bachhav, D. G., Deore, L. P., Wagh, Y. G., Tabassum, F., Yakin, J., Satvaldiyevich, S. S., Sharma, M., Thenge, R. R., & Mani, M. (2026). Formulation and Optimization of Misoprostol-Encapsulated Floating Microbeads for Gastric Ulcer Healing. Oriental Journal Of Chemistry, 2(42), 750. https://doi.org/10.13005/ojc/420236
Vancouver
Bachhav DG, Deore LP, Wagh YG, Tabassum F, Yakin J, Satvaldiyevich SS, et al. Formulation and Optimization of Misoprostol-Encapsulated Floating Microbeads for Gastric Ulcer Healing. Oriental Journal Of Chemistry. 2026;2(42):750. doi:10.13005/ojc/420236
BibTeX
@article{Bachhav2026,
author = {Bachhav, Devidas G. and Deore, Leena P. and Wagh, yoti Gorakh and Tabassum, Fauzia and Yakin, Josef and Satvaldiyevich, Saydaliyev Sultangazi and Sharma, Mansi and Thenge, Raju Ramesh and Mani, Munesh},
title = {Formulation and Optimization of Misoprostol-Encapsulated Floating Microbeads for Gastric Ulcer Healing},
journal = {Oriental Journal Of Chemistry},
year = {2026},
volume = {2},
number = {42},
pages = {750},
doi = {10.13005/ojc/420236}
}
EUVIMED